Clinical trials
Terminated Phase 1 Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| GlaxoSmithKline | 1 |
| M.D. Anderson Cancer Center | 1 |
| Theravance Biopharma | 1 |
| University of Alabama at Birmingham | 1 |
| University of California, Los Angeles | 1 |
| University of Maryland, Baltimore | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 7 |
| Carcinoma, Hepatocellular | 1 |
| Cholangiocarcinoma | 1 |
| Fatty Liver | 1 |
| Hepatopulmonary Syndrome | 1 |
| Hypoxia | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Keloid | 1 |
| Lung Diseases, Interstitial | 1 |
| Pulmonary Fibrosis | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.